An2 Therapeutics Inc (ANTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 8,598 | 14,014 | 15,880 | 18,296 | 18,815 |
| Operating Income | -8,598 | -14,014 | -15,880 | -18,296 | -18,815 |
| Other Income | 1,076 | 1,267 | 1,445 | 1,679 | 1,917 |
| Pre-tax Income | -7,522 | -12,747 | -14,435 | -16,617 | -16,898 |
| Net Income Continuous | -7,522 | -12,747 | -14,435 | -16,617 | -16,898 |
| Net Income | $-7,522 | $-12,747 | $-14,435 | $-16,617 | $-16,898 |
| EPS Basic Total Ops | -0.25 | -0.43 | -0.48 | -0.56 | -0.49 |
| EPS Basic Continuous Ops | -0.25 | -0.43 | -0.48 | -0.56 | -0.49 |
| EPS Diluted Total Ops | -0.25 | -0.43 | -0.48 | -0.56 | -0.49 |
| EPS Diluted Continuous Ops | -0.25 | -0.43 | -0.48 | -0.56 | -0.49 |
| EPS Diluted Before Non-Recurring Items | -0.25 | -0.43 | -0.48 | N/A | N/A |
| EBITDA(a) | $-9,165 | $-14,745 | $-16,770 | $-19,387 | $-20,121 |